Crunch time. Now we get to find out what we're doing, where we are going, who we are playing with and take away all the speculation, Ouija boards, rabbit's feet, hopes and prayers, finger crossing, side bets, etc.

Leronlimab's path to patients should be made clear with tons of lawyer litigation parting the way.